Marco Atteritano

Summary

Affiliation: University of Messina
Country: Italy

Publications

  1. ncbi request reprint Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study
    Marco Atteritano
    Department of Internal Medicine, University of Messina, Italy
    J Clin Endocrinol Metab 92:3068-75. 2007
  2. doi request reprint Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study
    Marco Atteritano
    Department of Internal Medicine, University of Messina, Italy
    Eur J Pharmacol 589:22-6. 2008
  3. doi request reprint The ESR2 AluI 1730G>A (rs4986938) gene polymorphism is associated with fibrinogen plasma levels in postmenopausal women
    Herbert Marini
    Department of Biochemical, Physiological and Nutritional Sciences, University of Messina, AOU Policlinico G Martino, Via C Valeria, Messina, Italy
    Gene 508:206-10. 2012
  4. doi request reprint Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study
    Herbert Marini
    Department of Biochemical, Physiological and Nutritional Sciences, Section of Physiology and Human Nutrition, University of Messina, 98125 Messina, Italy
    J Clin Endocrinol Metab 93:4787-96. 2008
  5. doi request reprint Genistein aglycone does not affect thyroid function: results from a three-year, randomized, double-blind, placebo-controlled trial
    Alessandra Bitto
    Department of Clinical and Experimental Medicine and Pharmacology, Section of Pharmacology, University of Messina, 98125 Messina, Italy
    J Clin Endocrinol Metab 95:3067-72. 2010
  6. ncbi request reprint Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial
    Herbert Marini
    Azienda Ospedaliera Universitaria Policlinico G Martino, University of Messina, Messina, Italy
    Ann Intern Med 146:839-47. 2007
  7. ncbi request reprint Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study
    Maria Letizia Cannata
    Department of Obstetrical and Gynaecological Sciences, University of Messina, Messina, Italy
    Menopause 14:648-55. 2007
  8. doi request reprint The ESR2 AluI gene polymorphism is associated with bone mineral density in postmenopausal women
    Monica Currò
    Department of Biochemical, Physiological and Nutritional Sciences, University of Messina, Via C Valeria, Policlinico G Martino, 98124 Messina, Italy
    J Steroid Biochem Mol Biol 127:413-7. 2011
  9. ncbi request reprint Neridronate prevents bone loss in patients receiving androgen deprivation therapy for prostate cancer
    Nancy Morabito
    Department of Internal Medicine, University of Messina, Messina, Italy
    J Bone Miner Res 19:1766-70. 2004
  10. doi request reprint Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression
    Marco Atteritano
    Department of Internal Medicine, University of Messina, Policlinico G Martino, Via C Valeria 1, 98123, Messina, Italy
    Intern Emerg Med 8:485-91. 2013

Collaborators

  • Alessandra Bitto
  • Rosario D'Anna
  • Antonino Santangelo
  • Giorgio Basile
  • Michele Buemi
  • Andrea Guala
  • Anna Meo
  • Onofrio Triolo
  • Vincenzo Adamo
  • Herbert Marini
  • Francesca Polito
  • Domenica Altavilla
  • Francesco Squadrito
  • Nicola Frisina
  • Maria Letizia Cannata
  • Agostino Gaudio
  • Francesco Corrado
  • Letteria Minutoli
  • Monica Currò
  • Antonino Catalano
  • Carla Lubrano
  • Elena Bianca Adamo
  • Alessia Frisina
  • Francesco Cancellieri
  • Susanna Mazzaferro
  • Antonino Lasco
  • Nancy Morabito
  • Daniela Caccamo
  • Riccardo Ientile
  • Angela Alibrandi
  • Elena B Adamo
  • Nadia Ferlazzo
  • Rolando Marini
  • Michele Bonaiuto
  • Steven Wilson
  • Nunziata Morabito
  • Domenico Cucinotta
  • Salvatore Condello
  • Vincenzo Di Stefano
  • Bruce P Burnett
  • Robert M Levy
  • Carlo Sansotta
  • Marianna Faraci
  • Giovanni Baviera
  • Francesco Antico
  • Mariangela La Rosa
  • Maria Antonia Pizzoleo
  • Roberta Guarino
  • Maria Cincotta
  • Giuseppina Anastasi
  • Aldo Trifiletti
  • Darwin Melloni

Detail Information

Publications13

  1. ncbi request reprint Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study
    Marco Atteritano
    Department of Internal Medicine, University of Messina, Italy
    J Clin Endocrinol Metab 92:3068-75. 2007
    ..Genistein, a soy isoflavone, has received wide attention over the last few years because of its potential preventive role for cardiovascular disease...
  2. doi request reprint Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study
    Marco Atteritano
    Department of Internal Medicine, University of Messina, Italy
    Eur J Pharmacol 589:22-6. 2008
    ..The protective effect on genomic damage appears to be a particularly promising tool in reducing the risk of cancer...
  3. doi request reprint The ESR2 AluI 1730G>A (rs4986938) gene polymorphism is associated with fibrinogen plasma levels in postmenopausal women
    Herbert Marini
    Department of Biochemical, Physiological and Nutritional Sciences, University of Messina, AOU Policlinico G Martino, Via C Valeria, Messina, Italy
    Gene 508:206-10. 2012
    ..The present data strongly indicate that genotyping for the ESR2 AluI 1730G>A gene variant should be included in a screening panel for assessment of cardiovascular risk in menopausal women...
  4. doi request reprint Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study
    Herbert Marini
    Department of Biochemical, Physiological and Nutritional Sciences, Section of Physiology and Human Nutrition, University of Messina, 98125 Messina, Italy
    J Clin Endocrinol Metab 93:4787-96. 2008
    ..Genistein aglycone improves bone metabolism in women. However, questions about the long-term safety of genistein on breast as well as its continued efficacy still remain...
  5. doi request reprint Genistein aglycone does not affect thyroid function: results from a three-year, randomized, double-blind, placebo-controlled trial
    Alessandra Bitto
    Department of Clinical and Experimental Medicine and Pharmacology, Section of Pharmacology, University of Messina, 98125 Messina, Italy
    J Clin Endocrinol Metab 95:3067-72. 2010
    ..Genistein aglycone positively affects postmenopausal symptoms. However, questions about its long-term safety on the thyroid gland still remain...
  6. ncbi request reprint Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women: a randomized trial
    Herbert Marini
    Azienda Ospedaliera Universitaria Policlinico G Martino, University of Messina, Messina, Italy
    Ann Intern Med 146:839-47. 2007
    ..Observational studies and small trials of short duration suggest that the isoflavone phytoestrogen genistein reduces bone loss, but the evidence is not definitive...
  7. ncbi request reprint Effects of the phytoestrogen genistein on hot flushes, endometrium, and vaginal epithelium in postmenopausal women: a 1-year randomized, double-blind, placebo-controlled study
    Maria Letizia Cannata
    Department of Obstetrical and Gynaecological Sciences, University of Messina, Messina, Italy
    Menopause 14:648-55. 2007
    ....
  8. doi request reprint The ESR2 AluI gene polymorphism is associated with bone mineral density in postmenopausal women
    Monica Currò
    Department of Biochemical, Physiological and Nutritional Sciences, University of Messina, Via C Valeria, Policlinico G Martino, 98124 Messina, Italy
    J Steroid Biochem Mol Biol 127:413-7. 2011
    ....
  9. ncbi request reprint Neridronate prevents bone loss in patients receiving androgen deprivation therapy for prostate cancer
    Nancy Morabito
    Department of Internal Medicine, University of Messina, Messina, Italy
    J Bone Miner Res 19:1766-70. 2004
    ..Neridronate, a relatively new bisphosphonate, is able to prevent bone loss in patients with prostate cancer during androgen ablation...
  10. doi request reprint Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression
    Marco Atteritano
    Department of Internal Medicine, University of Messina, Policlinico G Martino, Via C Valeria 1, 98123, Messina, Italy
    Intern Emerg Med 8:485-91. 2013
    ..Postmenopausal women with depressive disorder have an elevated risk for osteoporosis. Our data suggest that a high level of parathyroid hormone may play a role in the pathogenetic process underlying osteopenia in these patients. ..
  11. doi request reprint Vitamin D reduces musculoskeletal pain after infusion of zoledronic acid for postmenopausal osteoporosis
    Antonino Catalano
    Department of Internal Medicine, University of Messina, Messina, Italy
    Calcif Tissue Int 90:279-85. 2012
    ..005 vs. placebo). Our data demonstrate that cholecalciferol at a dose of 300,000 IU reduces the intensity of musculoskeletal pain after infusion of zoledronic acid for postmenopausal osteoporosis...
  12. ncbi request reprint Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle
    Nunziata Morabito
    Department of Internal Medicine, University of Messina, Messina, Italy
    J Bone Miner Res 19:722-7. 2004
    ..These data are extremely important for the possible therapeutic use of RANKL antagonists such as OPG in thalassemia-induced osteoporosis...
  13. doi request reprint OPG and sRANKL serum concentrations in osteopenic, postmenopausal women after 2-year genistein administration
    Herbert Marini
    Department of Biochemical, Physiological and Nutritional Sciences, Section of Physiology and Human Nutrition, A O U Policlinico G Martino, Messina, Italy
    J Bone Miner Res 23:715-20. 2008
    ..Genistein, an isoflavone representing 1-5% of total phytoestrogen content in soybean products, may positively regulate cellular bone metabolism, but its mechanism of action on bone is not yet fully understood...